Kazanılmış Epilepsiler
Özet
Kazanılmış epilepsiler; travma, inme ve beyin tümörleri gibi nörolojik hasarlar sonucunda gelişen ve ortak moleküler mekanizmalar (glutamat eksitotoksisitesi ve nöroinflamasyon) aracılığıyla ortaya çıkan klinik tablolardır. Hastalığın yönetimi, her bir etiyolojiye özgü epileptojenik süreçlerin anlaşılmasını ve buna uygun antiepileptik ilaç seçimini veya cerrahi müdahaleyi gerektirmektedir. Tedavi stratejileri, nöbet kontrolü sağlarken hastanın bilişsel ve davranışsal fonksiyonlarını korumayı hedefleyen, bireyselleştirilmiş klinik yaklaşımlara dayanmaktadır.
Acquired epilepsies arise from neurological damage caused by factors such as trauma, stroke, and tumors, which trigger shared molecular mechanisms like glutamate-induced neurotoxicity and inflammation. The management of these conditions requires an understanding of specific epileptogenic processes to guide tailored pharmacological interventions or, where necessary, surgical procedures. Treatment strategies prioritize achieving effective seizure control while carefully balancing antiepileptic drug selection with the patient's individual neurological and cognitive needs.
Referanslar
Fisher RS, Bonner AM.The Revised Definition and Classification of Epilepsy for Neurodiagnostic Technologists. Neurodiagn J. 2018;58(1):1-10.
Hauser WA, Hesdorffer DC. Epilepsy: Frequency, Causes and Consequences. New York: Demos; 1990.
Reddy DS, Bhimani A, Kuruba R, Park MJ, Sohrabji F. Prospects of modeling poststroke epileptogenesis. J Neurosci Res. 2017;95(4):1000-1016.
Senanayake N, Román GC. Epidemiology of epilepsy in developing countries. Bull World Health Organ. 1993;71(2):247-258.
Kvalsund MP, Birbeck GL. Epilepsy care challenges in developing countries. Curr Opin Neurol. 2012;25(2):179-186.
Pitkänen A. Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology. 2002 Nov 12; 59(9 Suppl 5):S27-33.
Michaels RL, Rothman SM. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J Neurosci. 1990;10(1):283-292.
Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988; 1(8):623-634.
Delorenzo RJ, Sun DA, Deshpande LS Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther. 2005;105(3):229-266.
Vezzani A. Epilepsy and inflammation in the brain: Overview and pathophysiology. Epilepsy Curr. 2014;14:3-7.
Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;8:728-741.
Bailey RC, Ullrich NJGoodkin HP, other Acquired Epilepsies: Trauma, Stroke, Tumors. In: Swaiman's Pediatric Neurology. Elsevier. 2018.p.590-3.
Corrigan JD, Selassie AW, Orman JA. The epidemiology of traumatic brain injury. J Head Trauma Rehabil. 2010;25:72-80.
D’Ambrosio R, Perucca E: Epilepsy after head injury. Curr Opin Neurol. 2004;17:731-735.
Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation. Practice parameter: antiepileptic drug treatment of posttraumatic seizures. Arch Phys Med Rehabil 1998;79:594-597.
Lowenstein DH. Epilepsy after head injury: an overview. Epilepsia. 2009;50(2, Suppl 2):4-9.
Scheffer IE, French J, Hirsch E et al (2016) Classification of the epilepsies: New concepts for discussion and debate. Special Report of the ILAE Classification Task Force of the Commission for Classification and Terminology. Epilepsia Open.
Tubi MA, Lutkenhoff E, Blanco MB, McArthur D, Villablanca P, Ellingson B, et al. Early seizures and temporal lobe trauma predict post‐traumatic epilepsy: a longitudinal study. Neurobiol Dis. 2018;123:115-121.
Garner R, La Rocca M, Vespa P, Jones N, Monti MM, Toga AW, Duncan D Imaging biomarkers of posttraumatic epileptogenesis. .Epilepsia. 2019 Nov;60(11):2151-2162.
Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology. 1980;30:683-689.
Jennett B. Epilepsy after non-missile head injuries. London:William Heinemann Medical Books, 1975.
Caveness WF. Epilepsy, a product of trauma in our time. Epilepsia. 1976;17:207-215.
Xu T, Yu X, Ou S, et al. Risk factors for posttraumatic epilepsy: A systematic review and meta-analysis. Epilepsy Behav. 2017;67:1-6.
Agrawal A, Timothy J, Pandit L, Manju M. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg. 2006;108(5):433-439.
Englander J, Bushnik T, Duong TT, et al. Analyzing risk factors for late posttraumatic seizures: a prospective, multicenter investigation. Arch Phys Med Rehabil. 2003;84(3):365-373.
Haltiner AM, Temkin NR, Dikmen SS. Risk of seizure recurrence after the first late posttraumatic seizure. Arch Phys Med Rehabil.1997;78:835-840.
Christensen J, Pedersen MG, Pedersen CB, Sidenius P, Olsen J, Vestergaard M. Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study. Lancet. 2009;373(9669):1105-1110.
Temkin NR. Risk factors for posttraumatic seizures in adults Epilepsia. 2003;44(10, Suppl 10):18-20.
Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998; 338(1):20-24.
Angeleri F, Majkowski J, Cacchio G, et al. Posttraumatic epilepsy risk factors: one-year prospective study after head injury. Epilepsia. 1999;40:1222-1230.
Russell WR. Cerebral involvement in head injury. Brain.1932;55:549-603.
Engel J Jr, Pitkanen A, Loeb JA, et al. Epilepsy biomarkers. Epilepsia. 2013;54:61-69.
Bar‐Klein G, Lublinsky S, Kamintsky L, et al. Imaging blood‐brain barrier dysfunction as a biomarker for epileptogenesis. Brain. 2017;140:1692-1705.
Buritica E, Villamil L, Guzman F, Escobar MI, Garcia‐Cairasco N, Pimienta HJ. Changes in calcium‐binding protein expression in human cortical contusion tissue. J Neurotrauma. 2009;26:2145-2155.
Pitkanen A, Kharatishvili I, Karhunen H, et al. Epileptogenesis in experimental models. Epilepsia. 2007;48:13-20.
Pitkänen A, Ekolle Ndode-Ekane X, Lapinlampi N, Puhakka N. Epilepsy biomarkers - Toward etiology and pathology specificity. Neurobiol Dis. 2019;123:42–58.
Ali I, Silva JC, Liu S, et al. Targeting neurodegeneration to prevent post-traumatic epilepsy. Neurobiol Dis . 2019;123:100-109.
Diamond ML, Ritter AC, Failla MD et al. IL-1-β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. Epilepsia. 2014;55:1109-1119.
Cotter D, Kelso A, Neligan A. Genetic biomarkers of posttraumatic epilepsy: a systematic review. Seizure 2017;46:53-58.
Zimmermann LL, Martin RM, Girgis F. Treatment options for posttraumatic epilepsy. Curr Opin Neurol. 2017;30(6):580-586.
D'Alessandro R, Tinuper P, Ferrara R, et al. CT scan prediction of late post‐traumatic epilepsy. J Neurol Neurosurg Psychiatry. 1982;45:1153-1155.
Agoston DV, Vink R, Helmy A, Risling M, Nelson D, Prins M. How to translate time: the temporal aspects of rodent and human pathobiological processes in traumatic brain injury. J Neurotrauma. 2019;36:1724-1737.
Siig Hausted H, Nielsen JF, Odgaard L. Epilepsy after severe traumatic brain injury: frequency and injury severity. Brain Inj. 2020;34(7):889-894.
Thompson K, La C, Abel H (2015) Pharmacological treatments for preventing epilepsy following traumatic head injury .Cochrane Database Syst Rev. 2015;8:1-56.
Beghi E. Overview of studies to prevent posttraumatic epilepsy. Epilepsia. 2003;44(s10):21-26.
Haltiner AM, Temkin NR, Dikmen SS. Risk of seizure recurrence after the first late posttraumatic seizure. Arch Phys Med Rehabil. 1997;78(8):835-840.
Kruer RM, Harris LH, Goodwin H, et al. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam. J Crit Care. 2013;28(5):883.e9–883.
Fordington S, Manford M. A review of seizures and epilepsy following traumatic brain injury. J Neurol. 2020;267(10):3105-3111.
Morris GL III, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(16):1453-1459.
Camfield P, Camfield C. When is it safe to discontinue AED treatment? Epilepsia. 2008;49(Suppl 9):25-28.
Strozzi I, Nolan SJ, Sperling MR, et al. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev. 2015; Cd001902.
Agrawal N, Johnston SC, Wu YW, et al. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke. 2009;40:3415-3421.
Zahuranec DB, Brown DL, Lisabeth LD, Morgenstern LB. Is it time for a large, collaborative study of pediatric stroke? Stroke. 2005;36:1825-1829.
Broderick J, Talbot GT, Prenger E, et al. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.
Aydinli N, Tatli B, Caliskan M, et al. Stroke in childhood: experience in Istanbul, Turkey. J Trop Pediatr. 2006;52:158-162.
deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000;15:316-324.
Beslow LA, Abend NS, Gindville MC, et al. Pediatric intracerebral hemorrhage: acute symptomatic seizures and epilepsy. JAMA Neurol. 2013;70:448-454.
Chadehumbe MA, Khatri P, Khoury JC, et al. Seizures are common in the acute setting of childhood stroke: a population-based study. J Child Neurol. 2009;24:9-12.
Breitweg I, Stülpnagel CV, Pieper T, et al. Eur J Early seizures predict the development of epilepsy in children and adolescents with stroke. Paediatr Neurol. 2017;21(3):465-467.
Fox CK, Glass HC, Sidney S, Lowenstein DH, Fullerton HJ. Acute seizures predict epilepsy after childhood stroke. Ann Neurol. 2013;74(2):249-256.
Zhang C, Wang X, Wang Y, et al. Risk factors for post-stroke seizures: a systematic review and meta-analysis. Epilepsy Res. 2014;108:1806-1816.
Tanaka T, Ihara M. Post-stroke epilepsy. Neurochem Int. 2017;107:219-228.
Chung JM. Seizures in the acute stroke setting. Neurol Res. 2014;36:403-406.
Yamada S, Nakagawa I, Tamura K, et al. Investigation of poststroke epilepsy (INPOSE) study: a multicenter prospective study for prediction of poststroke epilepsy. Neurol. 2020;267(11):3274-3281.
Bentes C, Pimentel J, Ferro JM. Epileptic seizures following subcortical infarcts. Cerebrovasc Dis. 2001;12:331-334.
So EL, Annegers JF, Hauser WA, O’Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology. 1996;46:350-355.
Okuda S, Takano S, Ueno M, Hamaguchi H, Kanda F. Clinical features of late-onset poststroke seizures. J Stroke Cerebrovasc Dis. 2012;21:583-586.
Kammersgaard LP, Olsen TS. Poststroke epilepsy in the Copenhagen stroke study: incidence and predictors. J Stroke Cerebrovasc Dis. 2005;14:210-214.
Lossius MI, Ronning OM, Slapo GD, et al. Poststroke epilepsy: occurrence and predictors-a longterm prospective controlled study (Akershus Stroke Study). Epilepsia. 2005;46:1246-1251.
Mecarelli O, Pro S, Randi F, et al. EEG patterns and epileptic seizures in acute phase stroke. Cerebrovasc Dis. 2011;31:191-198.
Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, Part I: indications. J Clin Neurophysiol. 2015;32:87-95.
Sacquegna T, de Carolis P, Crisci M, et al. Status epilepticus in acute ischemic stroke. Ital J Neurol Sci. 1995;16:453-457.
Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475-482.
Hesdorffer DC, Benn EKT, Cascino GD, Hauser WA. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009;50:1102-1108.
Hsu CJ, Weng WC, Peng SS, Lee WT Early-onset seizures are correlated with late-onset seizures in children with arterial ischemic stroke. .Stroke. 2014;45(4):1161-1163.
Zelano J, Holtkamp M, Agarwal N, Lattanzi S, Trinka E, Brigo F. How to diagnose and treat post-stroke seizures and epilepsy.bEpileptic Disord. 2020;22(3):252-263.
Ferro JM, Pinto F. Poststroke epilepsy: epidemiology, pathophysiology and management. Drugs Aging. 2004;21(10):639-653.
Nevitt SJ, Marson AG, Weston J, Tudur Smith C. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2017;2(2):CD001911.
Nolan SJ, Marson AG, Weston J, Tudur Smith C. Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. Cochrane Database Syst Rev. 2016;4(4):CD001769.
Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2017;12(12):CD011412.
Kolk A, Ennok M, Laugesaar R, et al. Long-term cognitive outcomes after pediatric stroke. Pediatr Neurol. 2011;44:101-109.
Keene DL, Hsu E, Ventureyra E. Brain tumors in childhood and adolescence. Pediatr Neurol. 1999;20(3):198-203.
Patel H, Garg BP, Salanova V, Boaz JC, Luerssen TG, Kalsbeck JE. Tumor-related epilepsy in children. J Child Neurol. 2001;16(2):141-145.
Williams BA, Abbott KJ, Manson JI. Cerebral tumors in children presenting with epilepsy. J Child Neurol. 1992;7(3):291-294.
Sjörs K, Blennow G, Lantz G. Seizures as the presenting symptom of brain tumors in children. Acta Paediatr. 1993;82:66-70.
Backus RE, Millichap GJ. The seizure as a manifestation of intracranial tumor in childhood. Pediatrics. 1962;6:978-984.
Low NL, Correll JW, Hammill JF. Tumors of the cerebral hemispheres in children. Arch Neurol. 1965;13:547-554.
Le Blanc FE, Rasmussen T: Cerebral seizures and brain tumors, in Vinken PJ, Bruyn GW (eds): Handbook of Neurology. Vol 15, The Epilepsies. New York, American Elsevier, 1974, 295-301.
Sjors K, Blennow G, Lantz G: Seizures as the presenting symptom of brain tumors in children. Acta Paediatr. 1993;82:66-70.
Shamji MF, Fric-Shamji EC, Benoit BG. Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev. 2009;32:274-284.
You G, Sha Z, Jiang T. The pathogenesis of tumor-related epilepsy and its implications for clinical treatment. Seizure. 2012;21:153-159.
Adamek D, Korzeniowska A, Morga R, et al. Dysembryoplastic neuroepithelial tumour (DNT): Is the mechanism of seizures related to glutamate? An immunohistochemical study. Folia Neuropathol. 2001;39:111-117.
Arai Y, Takashima S, Becker LE. Downregulation of glutamate receptor subunit 2(3) in subependymal giant cell tumor. Pediatr Neurol. 2000;23:37-41.
Huberfeld G, Vecht CJ. Seizures and gliomas – towards a single therapeutic approach. Nat Rev. 2016;12:204-216.
Rudà R, Trevisan E, Soffietti R. Epilepsy and brain tumors. Curr Opin Oncol. 2010;22:611-620.
Shuper A, Yaniv I, Michowitz S, Kornreich L, Schwartz M, Goldberg-Stern H, Cohen IJ. Epilepsy associated with pediatric brain tumors: the neuro-oncologic perspective. Pediatr Neurol. 2003;29(3):232-235.
Avila EK, Graber J. Seizures and epilepsy in cancer patients. Curr Neurol Neurosci Rep. 2010;10(1):60-67.
Wells EM, Gaillard WD, Packer RJ. Pediatric brain tumors and epilepsy. Semin Pediatr Neurol. 2012;19(1):3-8.
Tandon N, Esquenazi Y: Resection strategies in tumoral epilepsy: is a lesionectomy enough? Epilepsia. 2013;54 (Suppl 9):72-78.
van Breemen MSM, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421-430.
Smits A, Duffau H: Seizures and the natural history of World Health Organization grade II gliomas: A review. Neurosurgery. 2011;68:1326-1333.
Tandon N, Esquenazi Y: Resection strategies in tumoral epilepsy: is a lesionectomy enough? Epilepsia. 2013; 54 (Suppl 9):72-78.
van Breemen MSM, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421-430.
Lynam LM, Lyons MK, Drazkowski JF, Sirven JI, Noe KH, Zimmerman RS, et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg. 2007;109:634-638.
Michelucci R, Pasini E, Meletti S, Fallica E, Rizzi R, Florindo I, et al. Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study-Project of Emilia Romagna Region on Neuro-Oncology). Epilepsia. 2013;54:86-91.
Chen DY, Chen CC, Crawford JR, Wang SG. Tumor-related epilepsy: epidemiology, pathogenesis and management. J Neurooncol. 2018;139(1):13-21.
Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886-1893.
Rudà R, Soffietti R. What is new in the management of epilepsy in gliomas? Curr Treat Options Neurol. 2015;17(6):351.
Bedetti C, Romoli M, Maschio M, et al. Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study. Neurol. 2017;24(10):1283-1289.
Maschio M. Brain tumor-related epilepsy. Curr Neuropharmacol. 2012;10:124-133.
Kerkhof M, Dielemans JC, van Breemen MS, et al. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol. 2013;15(7):961-967.
Knudsen-Baas KM, Engeland A, Gilhus NE, Storstein AM, Owe JF. Does the choice of antiepileptic drug affect survival in glioblastoma patients? J Neurooncol. 2016;129:461-469.
Kim Y, Kim T, Joo J, Han JH, Kim YJ. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. Cancer. 2015;121:2926-2932.
Maschio M, Dinapoli L, Zarabla A, et al. Outcome and tolerability of topiramate in brain tumor associated epilepsy.J Neuro-Oncol. 2008;86:61-70.
Robert-Boire V, Desnous B, Lortie A, et al. Seizures in Pediatric Patients With Primary Brain Tumors. Pediatr Neurol. 2019;97:50-55.
Rudà R, Houillier C, Maschio M, et al. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES). Epilepsia. 2020;61(4):647-656.
Maschio M, Dinapoli L, Saveriano F, et al. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report. Acta Neurol Scand. 2009;120(3):210-212.
Khan RB, Hunt DL, Boop FA, Sanford RA, Merchant TE, Gajjar A, Kun LE Seizures in children with primary brain tumors: incidence and long-term outcome. Epilepsy Res. 2005;64(3):85-91.
Warren PP, Bebin EM, Nabors LB, Szaflarski JP. The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy. Neurocase. 2017;23(5-6):287-291.
Dewan MC, Thompson RC, Kalkanis SN, Barker 2nd FG, Hadjipanayis CG. Prophylactic antiepileptic drug administration following brain tumor resec-tion: results of a recent AANS/CNS Section on Tumors survey. J Neurosurg. 2016;24:1-7.
Swisher CB, Sinha SR. Survey of current practices among US epileptologists of antiepileptic drug withdrawal after epilepsy surgery. Epilepsy Behav. 2013;26:203-206.
